CyGene Introduces Their New Alcohol-Dependence DNA Analysis

Category: Press Releases | Permalink

Published: Thursday, August 06, 2009

CORAL SPRINGS, Fla.--(GLOBE NEWSWIRE)--CyGene Laboratories Inc. (OTC: CYGE - News) announced today that it is introducing an alcohol-dependence genetic profile product for the Eurasian market.

The company recently announced that it is providing direct-to-consumer predictive genetic products in the Russian Federation through its exclusive licensee CyGene Russia, LLC (www.cygenedirect.ru) and is expecting to expand its presence in Eastern Europe and Asia.

The new alcohol-dependence product analyzes variations in seven genes known to be associated with an increased risk for excessive alcohol consumption, substance abuse and some of the related complications with these behaviors. It is targeted geographically to the Eurasian market, because the genes chosen for the test panel relate to the ethnic composition of the region.

"This new product fits with CyGene's mission of providing genetic tests that are based on solid science, and that provide information that people can actually use to improve their lives," said Martin Munzer, CyGene's president and CEO.

"Scientific research is showing that genetics plays an important role in the progression and treatment of alcoholism. Variations in the tested genes have been associated with alcohol metabolism, detoxification, brain stimulating effects and the conferred increased risk for excessive substance and alcohol consumption, as well as increased risk for alcohol-related damage to the liver and pancreas."

CyGene currently markets a variety of DNA predictive genetic test panels that provide consumers with information on genetic predisposition to treatable conditions. CyGene is the only consumer genetic testing provider that guarantees anonymity to its customers, while providing access to the most updated science at the lowest possible price. The new Alcohol Dependence DNA Analysis is priced at $130 retail. Distributors are being recruited throughout the region and are invited to contact CyGene for information on how they can participate in the sale of CyGene's products.

About CyGene Laboratories Inc.

CyGene Laboratories Inc., based in Coral Springs, Fla., is a biotechnology company focused on introducing genetic predisposition and diagnostic testing into the general population. With five patents issued, CyGene's scientific expertise is in DNA analysis and diagnostic technologies. Incorporated in 1995, CyGene has been developing technology and introducing products that address the growing demand for genetic knowledge implementation and utilization. CyGene currently markets eight DNA predictive genetic test panels in accordance with its patent pending business model, sold direct to consumers and through physicians and other healthcare practitioners. CyGene's process offers customers access to the most updated science, guaranteeing their anonymity and keeping consumers on the cutting edge of genetic discoveries at the lowest possible price. The method allows customers who have purchased a previous genetic test panel a low cost upgrade to their genetic report as new genetic discoveries become available.

For more information about CyGene Laboratories and its products, visit the Company's Web site at:
www.CyGeneDirect.com

Contact:

Heidi Armstrong
Thorp & Company
(305) 446-2700
harmstrong@thorpco.com

Interest in CyGene DNA Consumer Testing Products Increases After Recent Media Coverage

Category: Press Releases

Published: Wednesday, May 12, 2010

CyGene Labs announces that it has experienced unprecedented levels of interest and requests for information following recent media coverage of Walgreens' decision to offer genetic testing kits supplied by Pathway Genomics in certain of their retail stores.

CyGene Laboratories Forms New International Sales Organization

Category: Press Releases

Published: Wednesday, April 28, 2010

CyGene announces that it has formed an international sales organization. This new organization was formed to help expand the number of sales channels for the company’s multiple DNA test panels, which are primarily marketed to consumers. Rodolfo E. Gonzalez will be heading this new organization as the Director of Global Development.

Los Angeles Times asks CyGene President Martin Munzer to Weigh in on Jamaican Sprinter Usain Bolt

Category: Media Room

Published: Friday, September 04, 2009

CyGene Laboratories is the industry leader in athletic performance genetic testing, helping everyone from professional athletes to weekend warriors achieve their optimal athletic goals. Company President Martin Munzer was recently quoted in an article appearing in the Los Angeles Times, weighing in on the athletic prowess of Jamaican sprinter Usain Bolt and how genetic testing is another tool for helping athletes achieve their goals.

CyGene’s CEO To Speak At Russian Academy of Sciences Diagnostics Conference

Category: Press Releases

Published: Friday, August 28, 2009

CyGene Russia, LLC, beginning to acquire recognition from the science circuit, has been invited to speak at the Russian Academy of Sciences diagnostics conference. CyGene’s CEO, Martin Munzer, will speak at the September 8th seminar and will cover “CyGene's products and technologies. CyGene is the first company to introduce predictive DNA tests and products to Russia, and the Vice President of the Far Eastern Public Academy of Sciences, Professor Iosif Piven, has high hopes for CyGene’s future.

CyGene Laboratories Inc. New Customer-Focused Website

Category: Press Releases

Published: Thursday, August 27, 2009

CyGene Laboratories Inc. has launched a consumer friendly website, with creative direction from Infinity Arts, the new website is easy to understand and navigate. The new website offers detailed information regarding genetics, genetic risk factors, understanding your personal DNA and simple instructions on self dna analysis. The site also features links to the company's blog and its social media sites.